Article

Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Journal of the American Academy of Dermatology
Volume 41, n° 6
pages 991-995 (décembre 1999)
Doi : 10.1016/S0190-9622(99)70259-8
No additional effect of calcipotriol ointment on low-dose narrow-band UVB phototherapy in psoriasis
 

S. Brands, MDa, M. Brakman, MDb, J.D. Bos, MD, PhDa, M.A. de Rie, MD, PhDa
Amsterdam and Delft, The Netherlands 
From the Department of Dermatology, Academic Medical Centre, University of Amsterdam,a and the Department of Dermatology, Reinier de Graaf Gasthuis, Delft.b 

Abstract

Background: Broad-band UVB phototherapy has appeared to be effective in clearing psoriatic lesions. After the advent of calcipotriol ointment, promising results have been obtained by combining these two therapeutic modalities. Also, an additional effect of narrow-band UVB phototherapy on treatment with calcipotriol ointment has been demonstrated. Objective: Our purpose was to compare treatment with low-dose narrow-band UVB phototherapy both with and without calcipotriol ointment. Methods: We included 53 patients suffering from plaque-type psoriasis. All patients underwent low-dose narrow-band UVB phototherapy. Nearly half of the patients were randomized to apply calcipotriol ointment (50 μg/g) twice daily on the affected skin. The Psoriasis Area and Severity Index (PASI) was used to evaluate psoriatic lesions. Results: In this study we showed that low-dose narrow-band UVB phototherapy is effective in the treatment of psoriasis and that calcipotriol ointment does not improve treatment outcome. Conclusion: Calcipotriol ointment does not improve treatment with low-dose narrow-band UVB phototherapy. (J Am Acad Dermatol 1999;41:991-5.)

The full text of this article is available in PDF format.

 Supported by LEO Pharmaceutical Products.
 Reprint requests: M. A. de Rie, MD, PhD, Department of Dermatology, Academic Medical Centre, University of Amsterdam, PO Box 22660, 1100 DD Amsterdam, The Netherlands.
 0190-9622/99/$8.00 + 0  16/1/101295



© 1999  American Academy of Dermatology, Inc. Published by Elsevier Masson SAS@@#104157@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline